A randomised controlled trial of a tele-based lifestyle intervention for colorectal cancer survivors ('CanChange'): study protocol by Hawkes, Anna et al.
BioMed CentralBMC Cancer
ssOpen AcceStudy protocol
A randomised controlled trial of a tele-based lifestyle intervention 
for colorectal cancer survivors ('CanChange'): study protocol
Anna L Hawkes*1,2, Kenneth I Pakenham3, Kerry S Courneya4, 
Sara Gollschewski1, Peter Baade1, Louisa G Gordon5, Brigid M Lynch6, 
Joanne F Aitken1 and Suzanne K Chambers1,7
Address: 1Viertel Centre for Research in Cancer Control, Cancer Council Queensland, Brisbane, Australia, 2School of Public Health, Queensland 
University of Technology, Brisbane, Australia, 3School of Psychology, The University of Queensland, Brisbane, Australia, 4Faculty of Physical 
Education and Recreation, University of Alberta, Edmonton, Canada, 5Queensland Institute of Medical Research, Brisbane, Australia, 6Cancer 
Prevention Research Centre, The University of Queensland, Brisbane, Australia and 7Griffith Institute for Health and Medical Research, Griffith 
University, Brisbane, Australia
Email: Anna L Hawkes* - annahawkes@cancerqld.org.au; Kenneth I Pakenham - k.pakenham@psy.uq.edu.au; 
Kerry S Courneya - kerry.courneya@ualberta.ca; Sara Gollschewski - saragollschewski@cancerqld.org.au; 
Peter Baade - PeterBaade@cancerqld.org.au; Louisa G Gordon - Louisa.Gordon@qimr.edu.au; Brigid M Lynch - b.lynch@sph.uq.edu.au; 
Joanne F Aitken - JoanneAitken@cancerqld.org.au; Suzanne K Chambers - SuzanneChambers@cancerqld.org.au 
* Corresponding author    
Abstract
Background: Colorectal cancer survivors may suffer from a range of ongoing psychosocial and
physical problems that negatively impact on quality of life. This paper presents the study protocol
for a novel telephone-delivered intervention to improve lifestyle factors and health outcomes for
colorectal cancer survivors.
Methods/Design: Approximately 350 recently diagnosed colorectal cancer survivors will be
recruited through the Queensland Cancer Registry and randomised to the intervention or control
condition. The intervention focuses on symptom management, lifestyle and psychosocial support
to assist participants to make improvements in lifestyle factors (physical activity, healthy diet,
weight management, and smoking cessation) and health outcomes. Participants will receive up to
11 telephone-delivered sessions over a 6 month period from a qualified health professional or
'health coach'. Data collection will occur at baseline (Time 1), post-intervention or six months
follow-up (Time 2), and at 12 months follow-up for longer term effects (Time 3). Primary outcome
measures will include physical activity, cancer-related fatigue and quality of life. A cost-effective
analysis of the costs and outcomes for survivors in the intervention and control conditions will be
conducted from the perspective of health care costs to the government.
Discussion: The study will provide valuable information about an innovative intervention to
improve lifestyle factors and health outcomes for colorectal cancer survivors.
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Colorectal cancer is the second most common cancer
worldwide [1] with approximately 60% of people diag-
nosed surviving the disease [2]. Cancer survivors report a
range of psychosocial and physical problems including:
depression and anxiety, lowered self-esteem and body
image; treatment side effects such as fatigue, pain, and
nausea; reduced cardiovascular function; and muscle
weakness [3,4]. An increasing incidence in cancer due to
an ageing population coupled with a growing incidence of
some cancers and improvements in early detection and
treatment has seen an increase in the number of cancer
survivors [5]. As such, there is increasing interest in how
to ameliorate the ongoing problems for this growing pop-
ulation to ultimately enhance quality of life [6,7].
It is estimated that up to 40% of colorectal cancer survi-
vors experience heightened psychological distress [8], and
a significant proportion are not meeting current public
health guidelines for lifestyle factors or health behaviours
[9,10]. In the first 12 months following diagnosis, approx-
imately 60% of colorectal cancer survivors are overweight,
70% are insufficiently active, and 22% are high risk drink-
ers [11]. Research has also shown that compared with
non-distressed survivors, the distressed group have an
increased likelihood of poor lifestyle factors including
smoking, physical inactivity and obesity [12]. Therefore, it
is clearly important to help survivors manage the adverse
psychosocial and physical consequences of colorectal can-
cer and its treatment.
The period after cancer diagnosis and treatment has been
described as a 'teachable moment". Despite the challenges
of cancer diagnoses and treatment, cancer survivors have
been found to be highly motivated to make behavioural
improvements to optimise their health and prevent cancer
recurrence [13-15]. Also, a growing body of research sug-
gests that the chronic and late effects of cancer treatment
are amenable to the same types of behavioural or lifestyle
interventions that are applied to other chronic disease
populations [16]. There have been several randomised
controlled trials (RCT) of lifestyle interventions for cancer
survivors that have resulted in improvements in a range of
health outcomes, although they have predominately
included breast cancer survivors [17]. Compared with
breast cancer survivors, colorectal cancer patients present
with more advanced disease, they undergo different med-
ical and surgical procedures, they tend to be older and
they include equal numbers of men and women. As such,
the results from previous studies cannot be easily general-
ised to colorectal cancer survivors [18-20].
There have only been a few trials to address the specific
needs of colorectal cancer survivors, including one RCT of
a psychosocial intervention [21] and one RCT of a lifestyle
intervention [18]. These studies have demonstrated effec-
tiveness although both identified a number of limitations.
The psychosocial trial included n = 249 survivors and the
intervention group (n = 125) received 10 home-visits over
two years from health professionals. The intervention
group had significantly lower occurrence of symptoms of
fatigue at three months follow-up, however there were no
intervention effects at two years. This study was limited by
differential compliance with the follow-up interviews,
and the control group received some psychosocial inter-
vention due to inexperienced staff. Furthermore, the con-
tent of the home visits was not theory-driven or structured
as the topics discussed were set by the participants [21].
The lifestyle trial [18] included 102 survivors and the
intervention group (n = 69) completed a home-based,
personalised exercise program for 20–30 minutes three to
five times per week. Intention-to-treat analyses revealed
no differences in quality of life between the intervention
and control groups, although exploratory analyses found
that intervention participants who increased their physi-
cal fitness reported higher levels of quality of life and
lower levels of anxiety and depression. Investigators
reported exercise contamination in the control group as
the study team contacted both the intervention and con-
trol participants weekly to report their exercise levels.
Previous research has suggested that interventions to
improve quality of life after colorectal cancer may be most
effective if they target symptom management, psychoso-
cial and lifestyle variables, or health behaviours, in a com-
prehensive and integrated approach [22]. Further,
patients have expressed the need for support with symp-
tom management, psychosocial and lifestyle factors fol-
lowing a diagnosis of colorectal cancer [23]. However,
despite the importance of comprehensive support and the
promising results of previous interventions, to our knowl-
edge there has been no previous trial of a broad and inte-
grated supportive care program for colorectal cancer
survivors. Accordingly, we have designed an intervention
that focuses on symptom management, psychosocial and
lifestyle support for recently diagnosed colorectal cancer
survivors.
The intervention includes an evidenced-based approach
with strategies drawn from the core components of
Acceptance and Commitment Therapy (ACT) [24-27].
ACT is an empirically based third generation cognitive
behavioural approach that uses acceptance and mindful-
ness strategies, and commitment and behaviour change
strategies to produce psychological flexibility: the ability
to defuse from difficult thoughts and accept difficult feel-
ings while persisting in values-based action [24-28] Psy-
chological flexibility is established through six core ACT
processes: acceptance, cognitive defusion (changing our
relationship with thoughts), being present, self-as-con-Page 2 of 8
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explicitly teaches strategies designed to increase tolerance
in the service of goal-directed behaviour, such as healthy
eating and physical activity.
Importantly, we are not trialling a psychotherapeutic
intervention; rather ACT strategies are used to enhance
positive lifestyle behaviours. We propose that ACT pro-
vides an alternative to existing intervention approaches
for cancer survivors, using specific strategies to overcome
internal barriers to making lifestyle improvements by
emphasizing the role of emotions and thoughts in the
maintenance of good self-management of lifestyle factors.
To date, ACT interventions have been successfully used to
enhance quality of life and promote positive lifestyle
behaviours for a range of health conditions including dia-
betes [29,30], chronic pain [31], smoking [32], epilepsy
[33], and obesity or weight management [34-38].
CanChange will overcome a number of the study limita-
tions of previous trials by trialling a comprehensive and
integrated intervention that is theory-based, structured
and promotes psychological flexibility to enhance behav-
iour change. As well, the intervention will be delivered by
highly skilled health professionals over the telephone.
Tele-based support has been shown to be highly accepta-
ble for people diagnosed with cancer [23,39,40], can over-
come geographical barriers to access, and can overcome
many of the reported barriers to participation in facility-
based support programs (e.g. transport, return to work, ill-
ness). In addition, telephone-delivered interventions are
convenient and flexible; they can be delivered at a suitable
time for the participant and in their own home; and
importantly they improve behavioural outcomes for can-
cer survivors [40]. Finally, telephone interventions may be
immediately translatable into broad-reach telephone hel-
plines that are used widely for cancer patients in Australia
and other countries. Whilst telephone interventions can-
not reach those without access to a telephone, in Aus-
tralia, approximately 96% of the population live in a
household with at least one telephone connection [41].
This paper presents the protocol for an RCT to evaluate
the effectiveness of an intervention to improve lifestyle
factors and health outcomes for colorectal cancer survi-
vors. We will also investigate the cost-effectiveness of the
intervention. We hypothesise that compared with partici-
pants receiving the control condition, intervention partic-
ipants will have improved lifestyle factors and health
outcomes. Additionally, we hypothesise that the interven-
tion will be cost-effective compared with the control con-
dition. The results of this study will provide valuable new
information about an intervention to improve lifestyle
behaviours and health outcomes for colorectal cancer sur-
vivors.
Methods/Design
Study Design
The study is a two-armed prospective RCT in which
approximately 350 colorectal cancer survivors will be ran-
domised in a 1:1 ratio to the intervention or control group
using a computer-generated random numbers sequence.
Participants in both groups will complete assessments at
baseline (Time 1), post-intervention or 6 months follow-
up (Time 2), and at 12 months follow-up for longer term
effects (Time 3).
Study Aims
i. To investigate the effect of a lifestyle intervention on life-
style factors and health outcomes [primary outcome vari-
ables include physical activity, cancer-related fatigue and
quality of life] at Time 2 and Time 3.
ii. To assess the cost-effectiveness of study participants
receiving the intervention in comparison with partici-
pants receiving the control condition.
Sample Recruitment Procedures
Ethics approval was received from Human Research Ethics
Committees of the University of Queensland's Behav-
ioural and Social Sciences Ethical Review Committee
(approval number 2007000656) and from 18 private and
public hospitals throughout Queensland. Eligibility crite-
ria include: (i) adult persons resident in Queensland; (ii)
a histologically confirmed diagnosis of primary colorectal
cancer (C18-C20, C218) within the previous 12 months
and notified to the Queensland Cancer Registry over a
nine month period (October 1st 2008 to June 30th 2009);
(iii) ability to understand and provide written informed
consent in English; (iv) no metastatic disease; (v) no med-
ical conditions that would limit adherence to an unsuper-
vised lifestyle program (as confirmed by their referring
physician); (vi) a telephone; and (vii) at least one poor
lifestyle factor [routinely exercise <150 minutes per week
[42], do not adhere to a healthy diet (indicated by < 2
serves fruit and 5 serves vegetables per day [43], or over-
weight (body mass index, BMI>=25) [44].
Based on Queensland incidence figures and available evi-
dence on the proportion of Queensland colorectal cancer
survivors with poor lifestyle behaviours (insufficiently
active, unhealthy diet or overweight) [11], we expect n =
875 potential participants over a nine month recruitment
period. Patients' names and their doctors will be obtained
from the Queensland Cancer Registry. As is required Reg-
istry procedure, initial letters will be sent to each patient's
doctor requesting doctor's permission to approach the
patient, followed by reminder telephone calls. With doc-
tor's permission, patients will be sent the consent package
and interested patients will provide written informed con-
sent in the presence of a witness.Page 3 of 8
(page number not for citation purposes)
BMC Cancer 2009, 9:286 http://www.biomedcentral.com/1471-2407/9/286Based on our past experience of recruiting colorectal can-
cer patients with this method, we anticipate approxi-
mately 80% of doctors will give permission for patients to
be contacted and approximately 60% of patients will con-
sent to participate. We therefore anticipate a final sample
size of approximately n = 350 eligible participants (n =
175 in the intervention and control conditions at Time 1).
Conservatively allowing for 20% attrition during the
intervention, we expect n = 140 subjects per condition at
Time 2. Sample size analysis indicated that 130 subjects
per condition (intervention and control) or a total of 260
were required to detect, with 80% power and type I error
of 5% (two-tailed), a moderate effect size in quality of life
of 0.35.
Upon receipt of the completed consent package, all
patients will be phoned by the project team to complete a
brief screening instrument to assess factors that would
exclude participation in the trial (physical activity using
the Godin Leisure-Time Exercise Questionnaire [45], fruit
and vegetable intake using brief questions developed by
the Cancer Council NSW [46], and BMI elicited from self
reported weight and height. Telephone interviewers will
then complete the Time 1 interview, and computer-gener-
ated randomisation to study condition will occur follow-
ing the completion of the Time 1 interview.
Randomisation will be conducted by the project manager
and concealed from investigators.
Study Conditions
Control
Control participants will receive existing educational bro-
chures produced by Cancer Council Australia on bowel
cancer and lifestyle factors. During the study period, they
will receive a quarterly study newsletter to enhance partic-
ipant retention, and will be contacted for all follow-up
assessments.
Intervention
The intervention will include (i) telephone delivered
health coaching sessions; (ii) participant handbook, (iii)
regular motivational postcard prompts; (iv) pedometer;
(v) and the quarterly study newsletter sent to control par-
ticipants. The intervention will be detailed in an interven-
tion manual including health coaching session scripts and
worksheets. The intervention will focus on symptom
management, as well as psychosocial and lifestyle support
to help participants manage the current and possible
future stresses associated with colorectal cancer and make
positive lifestyle changes. The intervention framework is
based on ACT as outlined previously [24,26] and limited
session content has been drawn from a current trial of a
psychosocial and physical activity intervention to
improve heart health [47].
The sessions will include: the cancer experience; colorectal
cancer-related symptoms; specific ACT components in
relation to lifestyle behaviours (values, mindfulness, defu-
sion or mindfulness of thoughts, acceptance or mindful-
ness of feelings, and committed action); and strategies to
enhance improvement in lifestyle behaviours consistent
with the national recommendations and individual goals
[42-44,48-51]. Intervention strategies will be consistent
with the session content including: ACT-strategies; moti-
vational interviewing; problem solving; action planning
and goal setting; as well as reviewing and ongoing moni-
toring.
The health coaching sessions will be delivered by study-
trained health coaches who will be guided by a custom
developed web-based computer application and will key
enter all session information. Health coaches will receive
comprehensive training in: colorectal cancer incidence,
treatment, symptoms and outcomes; ACT, behavioural
models of health and illness and behaviour change; as
well as national guidelines for lifestyle behaviours [42-
44,48-51]. Role-play and simulated calls will be con-
ducted to prepare health coaches for program delivery.
The first 10 sessions will be delivered bi-weekly over a five
month period, followed by the final telephone session
four weeks later to promote self management techniques
and long term maintenance of lifestyle improvements.
The participant handbook will include educational infor-
mation on lifestyle behaviours and the core components
of ACT. The handbook will also include additional infor-
mation sheets on common problems faced by colorectal
cancer survivors such as managing the side effects of treat-
ment, as well as tracking and monitoring tables for behav-
iour change.
Participants will receive motivational postcard prompts in
the mail between telephone sessions based on the previ-
ous session and action plan developed by the study partic-
ipant. These postcards will aim to promote behaviour
change and participant retention. Participants will also be
issued with a Yamax SW700 Multifunction Digi-Walker
pedometer at Time 1 to assist with the promotion of phys-
ical activity throughout the intervention. Health coaches
will explain how to use the pedometer and the handbook
will include an informational sheet. Participants will be
encouraged to achieve 10,000 steps a day, and to track and
monitor their steps throughout the intervention.
Study Integrity
The study design will be guided by the CONSORT state-
ment [52], and randomisation to study condition will
occur following the completion of Time 1 assessment.
Project staff tracking data collection will be blinded to
study condition. Randomisation will occur using blockPage 4 of 8
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cealed from investigators. The intervention protocol will
be manualised, and all intervention calls will be audio-
taped with a proportion reviewed to ensure adherence to
the delivery of the intervention protocol. All analyses will
be conducted on the basis of intention to treat.
Measurement
The majority of study data will be collected at Time 1,
Time 2 and Time 3 by computer assisted telephone inter-
view (CATI). Self-reported socio-demographic variables
will include gender, age, ethnicity, income, education,
employment status, and private health insurance status.
Medical information will include co-morbidities and
colorectal cancer treatment. Disease variables including
cancer grade and stage, as available, will be collected from
cancer registry records. To assess the implementation of
the intervention, we will measure intervention satisfac-
tion and quality of materials by self-administered ques-
tionnaire at Time 2, participant adherence to the
intervention and level of contact by data collected from
the web-based computer application, and delivery of the
intervention components through a health coaching ses-
sion checklist.
Implementation Evaluation
A self-administered satisfaction survey will be used to
measure satisfaction with specific aspects of the interven-
tion as well as overall satisfaction with the intervention.
Specific questions will address: the content (e.g. relevance
and usefulness of topics); the service (e.g. timing and
duration of calls, use of the telephone); the relationship
with the health coach (e.g. expectations met, feeling com-
fortable, level of rapport with the health coach); and the
intervention materials (e.g. relevance and readability of
the handbook and brochures). Participants will also be
asked to highlight the strengths and weaknesses of the
intervention in two open-ended questions.
The delivery of the intervention will be evaluated by an
objective assessor using a criterion based checklist for each
health coaching session. The criteria will include assess-
ment of health coaching skills used (e.g rapport building)
as well as a checklist against the content objectives for
each session (e.g. how well did the coach explain the pur-
pose of the call?). Participant adherence to the interven-
tion and level of contact will be assessed by: the
proportion of sessions completed during the intervention
period; the topics covered in each session; the total length
(minutes) of intervention exposure during the interven-
tion period; and the number of call attempts, missed calls
and reasons for missed calls. This data will be recorded by
health coaches on a web-based computer application
throughout the intervention.
Outcome Evaluation
Primary outcome variables
Physical activity
We will use a modified version of the leisure score index
of the Godin Leisure-Time Exercise Questionnaire that has
been shown to be a reliable and valid self-report measure
of physical activity[45]. The questionnaire contains three
questions that assess the average frequency of mild, mod-
erate, and strenuous exercise during free time in a typical
week. The modified version of the questionnaire also pro-
vides average duration.
Cancer-related fatigue
We will use the 13-item Functional Assessment of Chronic
Illness Therapy Fatigue Scale (FACT-FS) of the Functional
Assessment of Chronic Illness Therapy measurement sys-
tem which was developed specifically for the cancer pop-
ulation[53,54].
Quality of life
We will use the Short Form-36 (SF-36), a widely used
measure that has published norms for the Australian gen-
eral population[55,56]. The SF-36 contains a mental
health and physical health summary scale suitable to
measure the impact of the intervention on patients' well-
being, and generates a preference-based utility instrument
SF-6D which will be used in the cost-effectiveness analy-
ses.
Secondary Outcome Variables
Nutrition
We will use the Cancer Council Victoria Food Frequency
Questionnaire that shows acceptable levels of reliability
and validity when compared with seven-day weighted
food records, and has been successfully used over the tel-
ephone with cancer survivors[57].
Smoking
We will use brief questions about smoking behaviour
based on the commonly used Cancer Council New South
Wales validated items[46].
Weight management
Will be assessed by body mass index (BMI, kg/m2) and
waist circumference (cm). Participants will be provided
with tape measures for measurement of waist circumfer-
ence.
Psychological adjustment
We will use (a) the Brief Symptom Inventory (BSI-18) to
assess anxiety, depression and somatisation[58]; (b) the
Acceptance and Action Questionnaire (AAQ-II) to assess
experiential avoidance and the Mindful Attention Aware-
ness Scale (MAAS)[59] to assess mindfulness; and (c) The
post-traumatic growth inventory (PTGI) to assess growthPage 5 of 8
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Assessment of Chronic Illness Therapy Spiritual Well-
being module (FACIT-Sp)[61] to measure spirituality.
Colorectal cancer specific quality of life and physical symptoms
We will use the Functional Assessment of Chronic Illness
Therapy colorectal cancer (FACT-C) to measure quality of
life and colorectal cancer-specific symptoms [53,54].
Cost Effectiveness
In order to assess the economic value of the intervention,
several health outcome variables (detailed above) will be
combined with resource data to produce cost-effective-
ness ratios at Time 2. Taking a 'health system' perspective,
the types of resources in the analyses will include all inter-
vention resources recorded by the study manager (e.g.
health coach materials), participant health care utilisation
(e.g. hospital admissions), community health resources
and medications. Detailed data will be collected by self
report and validated with a randomised sub-sample of
20% of patient records and provider surveys. Resources
will be valued using nationally applicable sources (e.g.
Diagnosis-Related Group codes for hospital admissions
and Pharmaceutical Benefits Scheme cost codes for medi-
cations). All costs will be aggregated for the control and
intervention arms. The primary health benefit for the cost
effectiveness analyses will be quality-adjusted life years
(QALYs). Quality of life will be measured by the SF-36;
the SF6D algorithm will be used to produce QALY-
weights on a 0–1 scale. Secondary health benefits will
include the mean change in lifestyle factors and health
outcomes.
Data Analyses
Each hypothesis will be tested independently, taking into
account hypothesised predictors as well as potential con-
founding factors (e.g. age, gender). Multiple (linear,
multinomial or logistic) regression models will be fitted
to consider the relative strength of cross-sectional associa-
tions between primary outcome variables (continuous,
categorical or dichotomous) and patient characteristics.
Repeated-measures regression models will be used to ana-
lyse and summarise changes in primary outcome variables
over time and to determine the relationships with the var-
ious demographic, clinical, lifestyle, and psychosocial
characteristics over the three measured time points. The
effect of the intervention will be assessed by including a
dichotomous variable (control/intervention) in the
model, and assessing its interaction with the time-
dependent response variable. Repeated-measures regres-
sion models will use a generalised estimating equations
approach to account for the expected missing data due to
attrition over time. Variables measuring health outcomes
at Time 1 will be included in subsequent models to con-
trol for their effect on health outcomes in later time peri-
ods. Exploratory analyses on effect modification and
mediation will also be conducted. Effect modification will
be assessed through subgroup analyses and the introduc-
tion of interaction terms into the models to detect statisti-
cal differences between stratum-specific estimates.
Standard statistical software including STATA (STATA SE
10.0; StataCorp, College Station, TX), and SPSS (version
14.0 for Windows) will be used for analysis and data man-
agement.
For the cost effectiveness analyses, incremental cost-effec-
tiveness rations combining cost and health outcome data
will be calculated. The incremental difference in costs
between the 2 groups will be divided by the difference in
QALY's (and other secondary health benefits) between the
groups at Time 2 to generate the incremental cost-effec-
tiveness ratio. This represents the additional cost and
health effects of the intervention above the control condi-
tion. One-way sensitivity analyses will be undertaken to
test the robustness of the ratios to variation in key param-
eters. Detailed probabilistic (multivariate) sensitivity
analysis will be undertaken for all projections and param-
eters with uncertainty and/or variability using TreeAge Pro
2009 (Healthcare module) software (TreeAge Software
Inc, Williamstown, MA, USA).
Discussion
This study will trial a population based approach to pro-
mote lifestyle improvements and health outcomes for
colorectal cancer survivors. For colorectal cancer survi-
vors, no intervention studies to date have targeted the spe-
cific needs of colorectal cancer survivors in a
comprehensive and integrated intervention focusing on
symptom management, psychosocial and lifestyle sup-
port; or investigated the cost-effectiveness of this
approach. If successful, the intervention will be immedi-
ately translatable into practice by trained staff in a range
of settings including broad reach telephone help lines
available internationally, or through acute health care set-
tings.
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